Your browser doesn't support javascript.
loading
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Konnova, Angelina; De Winter, Fien H R; Gupta, Akshita; Verbruggen, Lise; Hotterbeekx, An; Berkell, Matilda; Teuwen, Laure-Anne; Vanhoutte, Greetje; Peeters, Bart; Raats, Silke; der Massen, Isolde Van; De Keersmaecker, Sven; Debie, Yana; Huizing, Manon; Pannus, Pieter; Neven, Kristof Y; Ariën, Kevin K; Martens, Geert A; Bulcke, Marc Van Den; Roelant, Ella; Desombere, Isabelle; Anguille, Sébastien; Berneman, Zwi; Goossens, Maria E; Goossens, Herman; Malhotra-Kumar, Surbhi; Tacconelli, Evelina; Vandamme, Timon; Peeters, Marc; van Dam, Peter; Kumar-Singh, Samir.
Afiliação
  • Konnova A; Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
  • De Winter FHR; Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Wilrijk, Belgium.
  • Gupta A; Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
  • Verbruggen L; Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
  • Hotterbeekx A; Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Wilrijk, Belgium.
  • Berkell M; Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.
  • Teuwen LA; Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
  • Vanhoutte G; Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
  • Peeters B; Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Wilrijk, Belgium.
  • Raats S; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
  • der Massen IV; Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.
  • De Keersmaecker S; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
  • Debie Y; Department of Laboratory Medicine, Antwerp University Hospital, Edegem, Belgium.
  • Huizing M; Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.
  • Pannus P; Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.
  • Neven KY; Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.
  • Ariën KK; Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.
  • Martens GA; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
  • Bulcke MVD; Biobank, Antwerp University Hospital, Edegem, Belgium.
  • Roelant E; Scientific Directorate Epidemiology and Public Health, Sciensano, Brussels, Belgium.
  • Desombere I; Scientific Directorate Epidemiology and Public Health, Sciensano, Brussels, Belgium.
  • Anguille S; Centre for Environmental Sciences, Hasselt University, Hasselt, Belgium.
  • Berneman Z; Federal Public Service (FPS) Health, Food Chain Safety and Environment, Brussels, Belgium.
  • Goossens ME; Virology Unit, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
  • Goossens H; Department of Biomedical Sciences, University of Antwerp, Edegem, Belgium.
  • Malhotra-Kumar S; Department of Laboratory Medicine, AZ Delta General Hospital, Roeselare, Belgium.
  • Tacconelli E; Scientific Directorate Epidemiology and Public Health, Sciensano, Brussels, Belgium.
  • Vandamme T; Clinical Trial Center (CTC), Clinical Research Centre (CRC) Antwerp, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.
  • Peeters M; StatUa, Center for Statistics, University of Antwerp, Antwerp, Belgium.
  • van Dam P; Service Immune response, Scientific Directorate Infectious Diseases in Humans, Sciensano, Brussels, Belgium.
  • Kumar-Singh S; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
Front Immunol ; 13: 1062136, 2022.
Article em En | MEDLINE | ID: mdl-36618384
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citocinas / COVID-19 / Vacina BNT162 / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citocinas / COVID-19 / Vacina BNT162 / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica